R Lahtinen
- Hematology top 1%
- Oncology top 5%
- Molecular Biology
- Genetics top 5%
- Pulmonary and Respiratory Medicine
- Co-authors
- Markku LaaksoPekka VirkkunenInkeri ElomaaI. P. PalvaAlbert de la ChapelleAllan RajamäkiTapani RuutuKari Pulkki
- Topics
- Acute Myeloid Leukemia Research (11 papers)Multiple Myeloma Research and Treatments (8 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers)
- Cited by
- HematologyOncologyGenetics
In The Last Decade
R Lahtinen
30 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 74
- Hematology 669
- Oncology 530
- Molecular Biology 247
- Genetics 164
- Pulmonary and Respiratory Medicine 145
Countries citing papers authored by R Lahtinen
This map shows the geographic impact of R Lahtinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Lahtinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Lahtinen more than expected).
Fields of papers citing papers by R Lahtinen
This network shows the impact of papers produced by R Lahtinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Lahtinen. The network helps show where R Lahtinen may publish in the future.
Co-authorship network of co-authors of R Lahtinen
This figure shows the co-authorship network connecting the top 25 collaborators of R Lahtinen. A scholar is included among the top collaborators of R Lahtinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Lahtinen. R Lahtinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 25 | |
| 3 | 71 | |
| 4 | 8 | |
| 5 | 39 | |
| 6 | 63 | |
| 7 | 21 | |
| 8 | 300 | |
| 9 | 5 | |
| 10 | 53 | |
| 11 | 23 | |
| 12 | 2 | |
| 13 | 56 | |
| 14 | 32 | |
| 15 | 44 | |
| 16 | 3 | |
| 17 | 15 | |
| 18 | 14 | |
| 19 | Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis. | 21 |
| 20 | 32 |
About R Lahtinen
R Lahtinen is a scholar working on Hematology, Genetics and Pharmacy, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (669 citations), Oncology (530 citations) and Genetics (164 citations). R Lahtinen has collaborated with scholars based in Finland, Sweden and Hungary. Frequent co-authors include Markku Laakso, Pekka Virkkunen, Inkeri Elomaa, I. P. Palva, Albert de la Chapelle, Allan Rajamäki, Tapani Ruutu, Kari Pulkki, Anri Tienhaara and T. Nousiainen. Their work appears in journals such as The Lancet, Blood and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.